Recently, there has been a revolution in our understanding of lung cancer biology with the detection of driver mutations such as epidermal growth factor receptor (EGFR) mutation as well as the exploration of the role of immune system dysfunction in cancer progression (16–18). Here, EGFR is linked to lung carcinoma.